Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALK Positive Canada is a patient-led, non-profit organization dedicated to improving the lives of Canadians affected by ALK-positive lung cancer. The organization focuses on four core pillars: community support, patient education, advocacy for equitable treatment access, and the funding of clinical research. By fostering a connected network of patients and caregivers across Canada, the group provides essential resources for navigating complex diagnosis and treatment pathways. ALK Positive Canada collaborates with thoracic oncologists, pharmaceutical partners, and global organizations like ALK Positive Inc. to drive progress toward a cure. Their advocacy efforts are particularly focused on improving the availability and public funding of targeted therapies within the Canadian healthcare system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ALK Positive Canada.